Tuesday, November 24, 2009

Money & Business

Many leads, many dead ends

Frustration inside the FBI's anthrax investigation: a so-far perfect crime

By Chitra Ragavan
Posted 4/7/02
Page 3 of 3

Rosenberg and some of her peers say they've named names to the FBI of who they think did it. The FBI says none has panned out (chemical analysis has shown the powder was not made using any known U.S. technique). Officials say Rosenberg is "misinformed and uninformed." The bureau also has pooh-poohed a recent memo written by two biodefense experts at Johns Hopkins University. They concluded that one of the hijackers who went to a Florida doctor last June seeking treatment of a "black lesion" or a "gash"--the description varies--probably suffered from cutaneous, or skin, anthrax. But the FBI says exhaustive testing for anthrax anywhere the hijackers were present came up empty.

In its investigation, the FBI has had other challenges. What if one of its scientific advisers is, in fact, the killer? Consider the story of William Patrick, patriarch of the nation's bioweapons program, owner of five patents for "weaponizing" anthrax. Patrick, who ran the offensive biological weapons program in the '60s at USAMRIID, says he wasn't approached until four months into the investigation. Feeling slighted, Patrick asked the FBI agent why it had taken so long. He says the agent replied, "Well, Mr. Patrick, you were a suspect." Patrick, 75, paused to digest that. "Well," he recalls telling the agent, "I suppose I was."

With Douglas Pasternak, Nell Boyce, David E. Kaplan and Nancy Shute

advertisement

advertisement

Special Reports

Paying for College

Paying for College

Colleges break links with lenders but now give less guidance to students on where to look.

NEWSLETTER

Sign up today for the latest headlines from U.S. News and World Report delivered to you free.

RSS FEEDS

Personalize your U.S. News with our feeds of blogs and breaking news headlines.

USNews MOBILE

U.S. News daily briefings are also available on your mobile device.

Use of this Web site constitutes acceptance of our Terms and Conditions of Use and Privacy Policy.